EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 30 April 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 1,201 - 1,300 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
6-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid	701-118-1	2156592-54-8	Repr. 1B; Eye Irrit. 2
4,4-isobutylethylidenediphenol AP-5	401-720-1	6807-17-6	Repr. 1B; Eye Irrit. 2
tetrahydrothiopyran-3-carboxaldehyde THTPA	407-330-8	61571-06-0	Repr. 1B; Eye Dam. 1
linuron (ISO); 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea	206-356-5	330-55-2	Repr. 1B; Carc. 2; Acute Tox. 4; STOT RE 2
gallium arsenide	215-114-8	1303-00-0	Repr. 1B; Carc. 1B; STOT RE 1
propiconazole(ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole	262-104-4	60207-90-1	Repr. 1B; Acute Tox. 4; Skin Sens. 1
flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one	262-661-3	61213-25-0	Repr. 1B; Acute Tox. 4; Skin Sens. 1
2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one	425-150-8	94723-86-1	Repr. 1B; Acute Tox. 4; Skin Sens. 1
tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine	246-347-3	24602-86-6	Repr. 1B; Acute Tox. 4; Skin Irrit. 2
imidazole	206-019-2	288-32-4	Repr. 1B; Acute Tox. 4; Skin Corr. 1C
methoxyacetic acid	210-894-6	625-45-6	Repr. 1B; Acute Tox. 4; Skin Corr. 1B
chloro-N, N-dimethylformiminium chloride SEL DE VILSMEIER-HAACK	425-970-6	3724-43-4	Repr. 1B; Acute Tox. 4; Skin Corr. 1A
sodium peroxoborate hexahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];sodium peroxoborate hexahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	-	-	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, monohydrate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid, sodium salt; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	234-390-0	11138-47-9	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (HBO(O2)), sodium salt, tetrahydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	600-611-8	10486-00-7	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
perboric acid (H3BO2(O2)), monosodium salt trihydrate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];perboric acid (H3BO2(O2)), monosodium salt, trihydrate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	603-902-8	13517-20-9	Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1
2,4,6-tri-tert-butylphenol	211-989-5	732-26-3	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1B
triflumizole (ISO); (1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine	614-708-8	68694-11-1	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which ''octyl'' is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups	254-408-0	39300-45-3	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Skin Sens. 1
3-methylpyrazole	215-925-7	1453-58-3	Repr. 1B; Acute Tox. 4; STOT RE 2; Skin Corr. 1; Eye Dam. 1
pentapotassium 2,2',2'',2''',2''''-(ethane-1,2-diylnitrilo)pentaacetate	404-290-3	7216-95-7	Repr. 1B; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
N-carboxymethyliminobis(ethylenenitrilo)tetra (acetic acid)	200-652-8	67-43-6	Repr. 1B; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate	205-391-3	140-01-2	Repr. 1B; Acute Tox. 4; STOT RE 2
ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol	603-038-1	125225-28-7	Repr. 1B; Acute Tox. 4; STOT RE 2
glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate	278-636-5	77182-82-2	Repr. 1B; Acute Tox. 4; STOT RE 2
etacelasil (ISO); 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane	253-704-7	37894-46-5	Repr. 1B; Acute Tox. 4; STOT RE 2
(1R,2S,5S)-2-[(4-chlorophenyl)methyl]-5-propan-2-yl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol	-	115937-89-8	Repr. 1B; Acute Tox. 4; STOT RE 2
(1R,2S,5R)-2-[(4-chlorophenyl)methyl]-5-propan-2-yl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol	-	115850-69-6	Repr. 1B; Acute Tox. 4; STOT RE 2
N, N-dimethylformamide; dimethyl formamide	200-679-5	68-12-2	Repr. 1B; Acute Tox. 4; Eye Irrit. 2
1,2,4-triazole	206-022-9	288-88-0	Repr. 1B; Acute Tox. 4; Eye Irrit. 2
Barium diboron tetraoxide	237-222-4	13701-59-2	Repr. 1B; Acute Tox. 4; Acute Tox. 3
N-methylformamide	204-624-6	123-39-7	Repr. 1B; Acute Tox. 4
N,N-dimethylacetamide	204-826-4	127-19-5	Repr. 1B; Acute Tox. 4
ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol	202-506-9	96-45-7	Repr. 1B; Acute Tox. 4
binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate	207-612-9	485-31-4	Repr. 1B; Acute Tox. 4
2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97	400-600-6	71868-10-5	Repr. 1B; Acute Tox. 4
2-methoxyethyl acetate; methylglycol acetate	203-772-9	110-49-6	Repr. 1B; Acute Tox. 4
ketoconazole; 1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone	265-667-4	65277-42-1	Repr. 1B; Acute Tox. 3; STOT RE 2
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol	619-020-1	94361-06-5	Repr. 1B; Acute Tox. 3; STOT RE 2
salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex show/hide Binapacryl EC / List no: 207-612-9 \| CAS no: 485-31-4 2-sec-butyl-4,6-dinitrophenol, compound with 2,2',2''-nitrilotriethanol (1:1) EC / List no: 229-166-4 \| CAS no: 6420-47-9 Dinoseb acetate EC / List no: 220-560-1 \| CAS no: 2813-95-8 2-sec-butyl-4,6-dinitrophenol, compound with 2,2'-iminodiethanol (1:1) EC / List no: 258-532-6 \| CAS no: 53404-43-6 Ammonium 2-sec-butyl-4,6-dinitrophenolate EC / List no: 228-858-3 \| CAS no: 6365-83-9 2-sec-butyl-4,6-dinitrophenol, compound with 1-aminopropan-2-ol (1:1) EC / List no: 275-931-0 \| CAS no: 71735-19-8 Sodium 2-(1-methylpropyl)-4,6-dinitrophenolate EC / List no: 252-331-7 \| CAS no: 35040-03-0	-	-	Repr. 1B; Acute Tox. 3; Eye Irrit. 2
dinoseb (ISO); 6-sec-butyl-2,4-dinitrophenol	201-861-7	88-85-7	Repr. 1B; Acute Tox. 3; Eye Irrit. 2
quinolin-8-ol; 8-hydroxyquinoline	205-711-1	148-24-3	Repr. 1B; Acute Tox. 3; Eye Dam. 1; Skin Sens. 1
tributyltin compounds, with the exception of those specified elsewhere in this Annex	-	-	Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Irrit. 2; Eye Irrit. 2
mercury	231-106-7	7439-97-6	Repr. 1B; Acute Tox. 2; STOT RE 1
dichlorodioctyl stannane	222-583-2	3542-36-7	Repr. 1B; Acute Tox. 2; STOT RE 1
pyrithione zinc; (T-4)-bis[1-(hydroxy-κO)pyridine-2(1H)-thionato-κS]zinc	236-671-3	13463-41-7	Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1
coumatetralyl; 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin	227-424-0	5836-29-3	Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1
salts and esters of dinoterb show/hide 2-tert-butyl-4,6-dinitrophenyl acetate EC / List no: 221-706-7 \| CAS no: 3204-27-1	-	-	Repr. 1B; Acute Tox. 2; Acute Tox. 3
dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol	215-813-8	1420-07-1	Repr. 1B; Acute Tox. 2; Acute Tox. 3
flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin FLOCOUMAFEN	421-960-0	90035-08-8	Repr. 1B; Acute Tox. 1; STOT RE 1
difethialone (ISO); 3-[3-(4'-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one	600-594-7	104653-34-1	Repr. 1B; Acute Tox. 1; STOT RE 1
chlorophacinone (ISO); 2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione	223-003-0	3691-35-8	Repr. 1B; Acute Tox. 1; STOT RE 1
bromadiolone (ISO); 3-[3-(4'-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one	249-205-9	28772-56-7	Repr. 1B; Acute Tox. 1; STOT RE 1
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin; difenacoum	259-978-4	56073-07-5	Repr. 1B; Acute Tox. 1; STOT RE 1
trixylyl phosphate	246-677-8	25155-23-1	Repr. 1B
tris(2-methoxyethoxy)vinylsilane; 6-(2-methoxyethoxy)-6-vinyl-2,5,7,10-tetraoxa-6-silaundecane	213-934-0	1067-53-4	Repr. 1B
theophylline; 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione	200-385-7	58-55-9	Repr. 1B
tetraboron disodium heptaoxide, hydrate	235-541-3	12267-73-1	Repr. 1B
reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate DYE K	402-660-9	-	Repr. 1B
reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene] diphenol (1:1)	-	-	Repr. 1B
reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl] phenolate (1:1)	-	-	Repr. 1B
orthoboric acid, sodium salt	237-560-2	13840-56-7	Repr. 1B
N-methylacetamide	201-182-6	79-16-3	Repr. 1B
N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one	220-250-6	2687-91-4	Repr. 1B
N, N-(dimethylamino)thioacetamide hydrochloride	435-470-1	27366-72-9	Repr. 1B
halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate	600-130-3	100784-20-1	Repr. 1B
formamide	200-842-0	75-12-7	Repr. 1B
fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate	274-125-6	69806-50-4	Repr. 1B
ethanol, 2,2'-iminobis-, N-(C13-15-branched and linear alkyl) derivs.	308-208-6	97925-95-6	Repr. 1B
disodium tetraborate, anhydrous	215-540-4	1330-43-4	Repr. 1B
Disodium tetraborate pentahydrate	601-808-1	12179-04-3	Repr. 1B
disodium tetraborate decahydrate	603-411-9	1303-96-4	Repr. 1B
disodium octaborate tetrahydrate	602-894-3	12280-03-4	Repr. 1B
disodium octaborate anhydrous	234-541-0	12008-41-2	Repr. 1B
diphenylether; octabromo derivate	251-087-9	32536-52-0	Repr. 1B
dimethomorph (ISO); (E,Z)-4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl) acryloyl)morpholine	404-200-2	110488-70-5	Repr. 1B
diisopentylphthalate	210-088-4	605-50-5	Repr. 1B
diisooctyl phthalate	248-523-5	27554-26-3	Repr. 1B
diisohexyl phthalate	276-090-2	71850-09-4	Repr. 1B
diisobutyl phthalate	201-553-2	84-69-5	Repr. 1B
dihexyl phthalate	201-559-5	84-75-3	Repr. 1B
dibutyl phthalate; DBP	201-557-4	84-74-2	Repr. 1B
diboron trioxide	215-125-8	1303-86-2	Repr. 1B
di-n-pentyl phthalate	205-017-9	131-18-0	Repr. 1B
boric acid	234-343-4	11113-50-1	Repr. 1B
boric acid	233-139-2	10043-35-3	Repr. 1B
bis(2-methoxyethyl) phthalate	204-212-6	117-82-8	Repr. 1B
bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP	204-211-0	117-81-7	Repr. 1B
bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme	205-594-7	143-24-8	Repr. 1B
benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1)	278-305-5	75768-65-9	Repr. 1B
benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate	479-100-5	577705-90-9	Repr. 1B
BBP; benzyl butyl phthalate e	201-622-7	85-68-7	Repr. 1B
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one [containing ≥ 0,5 % formamide (EC No 200-842-0)]	429-400-7	199327-61-2	Repr. 1B
6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid	701-162-1	-	Repr. 1B
6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol; [DBMC]	204-327-1	119-47-1	Repr. 1B
4,4'-sulphonyldiphenol; bisphenol S	201-250-5	80-09-1	Repr. 1B
4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene] diphenol; bisphenol AF	216-036-7	1478-61-1	Repr. 1B
2-methylimidazole	211-765-7	693-98-1	Repr. 1B
2-ethylhexanoic acid and its salts, with the exception of those specified elsewhere in this Annex show/hide 2-ethylhexanoic acid EC / List no: 205-743-6 \| CAS no: 149-57-5 Metal salts of 2-ethylhexanoic acid EC / List no: - \| CAS no: -	-	-	Repr. 1B
2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone CG 25-369; IRGACURE 369; TK 11-319	404-360-3	119313-12-1	Repr. 1B

Showing 1,201 - 1,300 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 30 April 2024. Database contains 4691 unique substances/entries.

Footer Nav Items